By Business/Source
Currency:USD
2023/FY
Stock NameRevenueRatio
Research and commercialization of exozyme biosolutions70.07K100.00%
By Country/Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States70.07K100.00%